You are here

JNJ

Big-sellers from Merck, Novo and Lilly likely to face Medicare price negotiations: report

Fierce Pharma

Tue, 02/28/23 - 10:39 pm

Boehringer Ingelheim

After spending $6.5B for Momenta, J&J readies 'pipeline in a product' for pivotal year

Fierce Biotech

Mon, 02/27/23 - 10:09 am

Momenta Pharmaceuticals

J&J wins EU backing for PARP combo Akeega in prostate cancer—but only in some patients

Fierce Pharma

Sun, 02/26/23 - 10:14 pm

prostate cancer

PARP inhibitors

J&J to impose new limits on 340B access after industry court win

Endpoints

Wed, 02/22/23 - 06:57 pm

Gilead, Teva and J&J's HIV antitrust case inches closer to trial as judge keeps most claims on the table

Fierce Pharma

Wed, 02/22/23 - 06:54 pm

Gilead Sciences

Teva Pharmaceutical

First FDA-Approved RSV Vaccines Expected Later This Year: The Top Vaccines And Their Effectiveness

Forbes

Mon, 02/20/23 - 12:37 pm

Moderna Therapeutics

Janssen Returns Phase I NASH Candidate to Arrowhead

BioSpace

Wed, 02/15/23 - 06:08 pm

Arrowhead Pharmaceuticals

Judge indicates intention to dismiss J&J talc unit bankruptcy

Reuters

Wed, 02/15/23 - 10:44 am

Alcon to pay Johnson & Johnson $199 mln to settle eye-laser cases

Marketscreener

Mon, 02/13/23 - 10:09 pm

intellectual property

Roche expands collaboration with Janssen to advance personalised healthcare through companion diagnostics

BioSpace

Thu, 02/9/23 - 10:53 am

companion diagnostics

J&J's Monarch Assists in Kidney Stone Removal

Medical Devices and Diagnostics Industry

Wed, 02/8/23 - 10:55 pm

J&J, Medtronic, Boston Scientific seek growing share of U.S. market for cardiac ablation

Medtech Dive

Wed, 02/8/23 - 10:37 am

Boston Scientific

J&J clears PhII for rare blood disorder with drug from $6.5B Momenta buyout

Endpoints

Mon, 02/6/23 - 10:41 am

clinical trials

J&J's pharma group quietly works through global overhaul, with layoffs expected to reach multiple countries

Fierce Pharma

Fri, 02/3/23 - 10:56 am

Janssen laying off 4 dozen employees as California plant heads toward closure

Fierce Pharma

Thu, 02/2/23 - 10:59 pm

drug manufacturing

Appeals court tosses J&J's controversial 'Texas two-step' bankruptcy case

Endpoints

Mon, 01/30/23 - 05:52 pm

J&J, Legend’s cancer cell therapy has early success in key clinical trial

BioPharma Dive

Mon, 01/30/23 - 10:27 am

Multiple Myeloma

clinical trials

J&J copay lawsuit against drug benefit firm gets green light

Pharmaphorum

Fri, 01/27/23 - 10:52 am

J&J quietly punts a pair of early-stage bispecifics for solid tumors

Endpoints

Thu, 01/26/23 - 10:45 am

bispecific antibodies

Pages